PHARMA THIRD PARTY CONTRACT MANUFACTURER OF FEBUXOSTAT
Febuxostat is associated with the family of Non-purine-selective Xanthine oxidase inhibitors. Febuxostat is used against the production of uric acid in the body.
Class Xanthine oxidase inhibitors
Mechanism of action
Febuxostat is an inhibitor of Xanthine oxidase active site that is a molybdenum center for reducing the excess of uric acid production in the body.
Absorption of Febuxostat –less than 49%
Protein binding of Febuxostat-99.2%
A half-life of Febuxostat-5-8 hours
Elimination-Hepatic & renal
Febuxostat is prescribed for lowering the uric acid production in chronic gout & Hyperuricemia. It may also be prescribed in attacks of redness, swelling, pain & heat in joints.
Nausea & headache
Hepatic serum enzymes increases
The dark color of urine
Chest pain & heavy feeling
Visual disturbance & confusion
Sweating & feeling of illness
Ambroxol acefylline, Theophylline (it decreases the serum concentration)
Sarilumab (increases immunosuppressant activity)
Azathioprine & Mercaptopurine
Each tablet of Febuxostat contains 40mg or 80 mg of active product & the recommended dose is one tablet per day at the same time or consults with your doctor or pharmacist (healthcare professional)
We are the supplier of Febuxostat & also a trader of Febuxostat.
*The following symptoms are suggestive & needs to be confirmed before promoting or coating anywhere & anybody whom so ever. Power2pharma.com & its parent company NEWS pharma Pvt. Ltd. is not responsible for its authenticity.